Skip to content
Free shipping  ·  Cancel anytime  ·  Licensed US clinicians in all 50 states
Womea
Blog

Low libido in menopause: causes and evidence-based options

Low libido in menopause is common and usually has several causes at once — hormonal shifts, painful intimacy, poor sleep, and mood. Here is what the evidence supports, and an honest look at where testosterone fits.

May 1, 20268 min readMedically reviewed by Sean Arora, MD

Low libido in menopause is caused by several overlapping factors at once — falling estrogen, painful intimacy, disrupted sleep, mood changes, and certain medications — rather than a single trigger. Because causes stack, the most effective approach treats the fixable contributors first, then considers desire-specific therapy such as testosterone only if distressing low desire persists.

Why does libido drop during menopause?

Desire in midlife is shaped by biology, comfort, and context together. Estrogen decline reduces vaginal lubrication and elasticity, which can make sex uncomfortable and, understandably, less appealing. Night sweats fragment sleep, and exhaustion blunts interest. Anxiety and low mood, which often rise in the transition, further dampen desire. Androgen levels also gradually decline with age. Untangling which factors matter most for you is the foundation of effective care.

  • Vaginal dryness and painful intimacy from low estrogen, which make sex less comfortable.
  • Poor sleep from night sweats, leaving little energy for intimacy.
  • Anxiety, low mood, or stress, which directly reduce desire.
  • Relationship dynamics and life stress in midlife.
  • Certain medications, including some antidepressants, that can lower libido.

What helps low libido in menopause?

The most reliable gains often come from removing the obstacles rather than chasing desire directly. If intimacy is painful, treating the genitourinary syndrome of menopause frequently restores comfort and, with it, interest. Low-dose vaginal estradiol — such as an estradiol vaginal cream — rebuilds vaginal tissue and reduces pain. If night sweats are wrecking sleep, systemic estradiol (with micronized progesterone for women who have a uterus) can restore rest and energy. If mood is the driver, addressing it directly matters.

  • Treat painful sex first — vaginal estradiol often restores comfort and desire follows.
  • Improve sleep — estradiol, paired with micronized progesterone where a uterus is present, can ease night sweats that drain energy.
  • Address mood and stress, which are powerful, often-overlooked drivers of desire.
  • Review medications with your clinician, since some can lower libido and alternatives may exist.
Treating contributing factors such as genitourinary symptoms, sleep disruption, and mood is a first-line approach to low sexual desire in the menopause transition.
The Menopause Society
Common contributors to low libido and how they are addressed
Contributing factorHow it lowers desireFirst-line approach
Vaginal dryness / painful sexMakes intimacy uncomfortable or painfulVaginal estradiol restores tissue and comfort
Night sweats and poor sleepFatigue blunts interest in intimacySystemic estradiol (plus progesterone if a uterus is present)
Anxiety or low moodDirectly dampens sexual desireAddress mood and stress with your clinician
Medications (e.g., some antidepressants)Can suppress libido as a side effectReview options and alternatives with your clinician
Persistent HSDD after the aboveDistressing low desire despite treating other causesTestosterone, off-label and clinician-monitored

Where does testosterone fit?

Testosterone is the best-evidenced medical treatment specifically for hypoactive sexual desire disorder (HSDD) in postmenopausal women — meaning distressing low desire that persists after other contributing factors have been addressed. The important caveat is that there is no testosterone product approved for women in the United States. Any use is off-label, typically compounded, and requires careful, clinician-monitored dosing to keep levels in the female physiologic range. It is a considered option, discussed with a clinician, not a first step.

Testosterone, dosed to female physiologic concentrations, can be effective for hypoactive sexual desire disorder in postmenopausal women, but no formulation is currently approved for use in women.
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
Womea currently offers hormone therapy and Estradiol Vaginal Cream. Womea does not currently offer testosterone. If testosterone is something you want to explore, discuss it with a US-licensed clinician, who can explain the off-label, monitored nature of that option.

The bottom line

Low libido in menopause is common, multi-causal, and very often improvable. The most effective path usually starts by treating the fixable contributors — painful intimacy, poor sleep, and mood — with proven, evidence-based options, and only then considering desire-specific therapy such as testosterone, which has no product approved for women and requires clinician monitoring. There are no guaranteed outcomes, but for most women meaningful improvement is realistic with an individualized, evidence-based plan.

FAQ

Questions, answered

Usually several causes overlap: low estrogen causing vaginal dryness and painful sex, disrupted sleep from night sweats, mood changes, relationship and life stress, and sometimes medications. Identifying the main drivers for you is the key to treating it effectively.

Feel like yourself again.

Take the 3-minute assessment, then meet your clinician by video or phone. No obligation.